Benjamin has conducted analyses in support of FDA and global regulatory approval of new medical technologies at Evidera, United Biosource corporation, and Abt Biopharma solutions since 2008. As a researcher and project manager, he’s written extensive meta-analyses covering disease areas such as type 2 diabetes, non-Hodgkin lymphoma, cardiovascular disease, bone cancer in children, chronic lower back pain, HPV, and hepatitis C. Ben graduated with a Bachelors of Science in Biology from the University of Massachusetts, Amherst, and has always considered himself a consumer advocate. He started his career as a lab-based researcher at the United States Geological Survey (USGS), investigating agriculture-related environmental contaminants in wastewater and local wetlands, and quickly moved from there into the field of public health. Ben cares deeply about honesty, integrity, and the pursuit of evidence-based knowledge for the betterment of society.
BS: Biology - University of Massachusetts, Amherst